Key facts
- It has raised $27.9M; the latest was Early Stage VC ($13.9M) in Sep 2025.
- Notable investors include Shunwei Capital, Highlight Capital, Tsing Stone Asset Management, Insight Capital (Taicang), CVCapital — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Sierra Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Sierra Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sierra Medical Technology
Developer of high end instruments designed for ophthalmology. The company focuses on developing medical instruments, equipment that are used in the drug making, analysis process, providing advanced instruments for ophthalmic medical users.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2022
- Website
- sierramed.com.cn/
- Ownership
- Privately Held (backing)
Sierra Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sierra Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sierra Medical Technology in its N-PORT filings yet. We sweep new filings monthly.